Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2025 · 64 positions · Total reported value $129.64M · Top-10 concentration 55.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2025 13F filing, Stonepine Capital Management, LLC disclosed 64 equity positions with a combined reported value of $129.64M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 55.0% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2025 were VSTM ($21.09M), ADMA ($13.50M), EOLS ($10.85M). By sector, the heaviest allocations are Health Care 92.6%, Real Estate 1.9%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp), Real Estate (+1.9pp) and away from Other (-5.6pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 42% of names.

The largest new positions opened in Q4 2025 were CRBP ($3.17M), KZIA ($3.17M), VRCA ($2.94M).

Of the 29 positions fully exited versus the prior quarter, the largest were SLNO ($1.62M), ALMS ($1.20M), ARDX ($1.10M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • CRBP CORBUS PHARMACEUTICALS HLDGS · $3.17M
  • KZIA KAZIA THERAPEUTICS LTD · $3.17M
  • VRCA VERRICA PHARMACEUTICALS INC · $2.94M
  • HELP CYBIN INC · $2.78M
  • CRSP CRISPR THERAPEUTICS AG · $2.62M
  • ARE ALEXANDRIA REAL ESTATE EQ IN · $2.45M
  • ACET ADICET BIO INC · $1.85M
  • SPRB SPRUCE BIOSCIENCES INC · $1.72M

Fully Exited (vs previous quarter)

  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $1.62M
  • ALMS ALUMIS INC · prev qtr: $1.20M · history
  • ARDX ARDELYX INC · prev qtr: $1.10M
  • DVAX DYNAVAX TECHNOLOGIES CORP · prev qtr: $1.07M
  • VNDA VANDA PHARMACEUTICALS INC · prev qtr: $973.05K
  • VIR VIR BIOTECHNOLOGY INC · prev qtr: $913.60K
  • ANGO ANGIODYNAMICS INC · prev qtr: $670.20K
  • GRCE GRACE THERAPEUTICS INC · prev qtr: $628.18K

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 92.6%
Other 5.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.73M $21.09M 16.27%
16.27%
Add
2 740.00K $13.50M 10.41%
10.41%
Hold
3 1.63M $10.85M 8.37%
8.37%
Add
4 569.09K $5.10M 3.93%
3.93%
Reduce
5 2.35M $4.81M 3.71%
3.71%
Add
6 100.00K $3.59M 2.77%
2.77%
Hold
7 389.92K $3.17M 2.45%
2.45%
New
8 460.36K $3.17M 2.45%
2.45%
New
9 115.00K $3.06M 2.36%
2.36%
Hold
10 353.67K $2.94M 2.27%
2.27%
New
11 339.90K $2.78M 2.15%
2.15%
New
12 2.35M $2.78M 2.14%
2.14%
Add
13 100.00K $2.67M 2.06%
2.06%
Reduce
14 50.00K $2.62M 2.02%
2.02%
New
15 113.63K $2.57M 1.98%
1.98%
Reduce
16 50.00K $2.45M 1.89%
1.89%
New
17 593.57K $2.37M 1.83%
1.83%
Reduce
18 100.00K $2.30M 1.77%
1.77%
Add
19 813.70K $2.12M 1.63%
1.63%
Reduce
20 50.00K $2.11M 1.63%
1.63%
Reduce
21 200.00K $1.86M 1.44%
1.44%
Reduce
22 220.01K $1.85M 1.43%
1.43%
New
23 19.74K $1.72M 1.33%
1.33%
New
24 1.24M $1.61M 1.24%
1.24%
Add
25 100.00K $1.58M 1.22%
1.22%
Reduce
26 1.15M $1.44M 1.11%
1.11%
Reduce
27 228.89K $1.40M 1.08%
1.08%
New
28 893.10K $1.35M 1.04%
1.04%
New
29 662.67K $1.34M 1.03%
1.03%
New
30 701.00K $1.30M 1.00%
1.00%
Reduce
31 78.19K $1.13M 0.87%
0.87%
New
32 486.40K $1.07M 0.83%
0.83%
Reduce
33 805.80K $1.06M 0.82%
0.82%
Reduce
34 200.00K $1.05M 0.81%
0.81%
Reduce
35 87.68K $1.04M 0.80%
0.80%
New
36 156.18K $982.37K 0.76%
0.76%
Reduce
37 687.50K $976.25K 0.75%
0.75%
Hold
38 710.07K $852.09K 0.66%
0.66%
Add
39 51.00M $850.85K 0.66%
0.66%
New
40 50.00K $764.50K 0.59%
0.59%
New
41 469.02K $726.98K 0.56%
0.56%
Add
42 627.67K $715.54K 0.55%
0.55%
Add
43 204.77K $634.79K 0.49%
0.49%
Hold
44 463.70K $626.00K 0.48%
0.48%
Add
45 45.00K $595.35K 0.46%
0.46%
Reduce
46 86.36K $489.66K 0.38%
0.38%
Reduce
47 305.40K $467.26K 0.36%
0.36%
New
48 256.11K $417.45K 0.32%
0.32%
Add
49 164.89K $385.85K 0.30%
0.30%
Add
50 50.00K $385.00K 0.30%
0.30%
New

FAQ

What did Stonepine Capital Management, LLC buy in 2025-Q4?

In its 2025-Q4 13F filing, Stonepine Capital Management, LLC reported 64 equity positions worth $129.64M in aggregate; its largest disclosed positions were VSTM ($21.09M), ADMA ($13.50M), EOLS ($10.85M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $129.64M of long equity holdings across 64 positions as of 2025-Q4. Top-10 holdings account for 55.0% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →